iRhythm Holdings, Inc. - Common Stock (IRTC)

iRhythm Technologies (NASDAQ:IRTC) raised its 2026 revenue and profitability outlook after reporting third-quarter growth driven by its core Zio monitor business, even as demand for its Zio AT telemetry product fell short of expectations. The cardiac monitoring company reported revenue of $221.6 mi

Zio AT softened as buyers waited on VitalConnect, yet margins surged.

Medical technology company iRhythm Technologies (NASDAQ:IRTC) met Wall Street’s revenue expectations in Q3 2026, with sales up 14.9% year on year to $221.6 m...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Medical technology company iRhythm Technologies (NASDAQ:IRTC) met Wall Street’s revenue expectations in Q3 2026, with revenue up 14.9% year on year to $221.6...

What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat...

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results this Thursday afternoon. Here’s what you need to know. iRhy...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo...

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. A lack ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how patient monitoring sto...

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...

Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulator...

iRhythm’s stock price has taken a beating over the past six months, shedding 27.5% of its value and falling to $115.17 per share. This may have investors won...

Revenue jumped 20% while margins expanded, and the company raised full-year guidance.

iRhythm’s second quarter results were met with a strong positive market reaction, reflecting the company’s ability to deliver both robust revenue growth and ...

What Happened? Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) fell 2.8% in the afternoon session after a significant price target cu...

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...

What Happened? Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 2% in the afternoon session after the company reported strong s...

Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 20.1% yea...

iRhythm Technologies (NASDAQ:IRTC) reported second-quarter revenue growth of 20.1% and raised its full-year outlook, while announcing an agreement to acquire VitalConnect to broaden its cardiac monitoring portfolio and enter additional patient-monitoring markets. Revenue for the quarter ended at $2

Medical technology company iRhythm Technologies (NASDAQ:IRTC) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 20.1% year on year to $224....

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting results this Thursday after market hours. Here’s what to look for. iRhythm be...